ArticleWorld journal of urology2026
Impact of continuous local anesthetic wound infiltration on postoperative outcomes following open radical cystectomy: a comprehensive evaluation.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate continuous wound infiltration (CWI) as an alternative to thoracic epidural analgesia (TEA) for postoperative recovery after open radical cystectomy within an ERAS® pathway. MATERIALS AND
methodsRetrospective before–after cohort at a Swiss tertiary center using a prospectively maintained ERAS® database (TEA: Nov 2012–May 2016; CWI: Jun 2016–Mar 2024). Adults undergoing open cystectomy with extended pelvic lymphadenectomy and ileal conduit or neobladder were included (CWI = 154; TEA = 88). Outcomes were daily pain (VAS 0–10), nausea, opioid rescue (POD0–3), gastrointestinal recovery (first stool; tolerance of solid food), length of stay (LOS), and 90-day complications. Mixed-effects and multivariable models adjusted for prespecified covariates.
resultsPain scores were lower with TEA on POD0–3, whereas CWI had less postoperative nausea. CWI showed faster bowel recovery (first stool median 5 vs. 6 days, p = 0.02) and earlier tolerance of solid food (median 5 vs. 11 days, p < 0.001; adjusted β − 4.4 days, 95% CI − 6.8 to − 2.1). LOS was shorter with CWI (median 15 vs. 24 days, p < 0.001; adjusted β − 5.0 days, 95% CI − 9.1 to − 1.0). Early opioid rescue was more frequent with CWI, attenuating by POD3. No CWI catheter-related complications occurred.
conclusionWithin ERAS®, CWI with ropivacaine is a clinically acceptable alternative to TEA after open RC, trading slightly higher early pain for faster gastrointestinal recovery and a shorter LOS.
Indexed as
Identifiers
42001333What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.